HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners By 31 March 2025
Temasek-backed 65 Equity Partners sees global firms as possible source for IPO pipeline By 24 March 2025
